Research Article
Clinical Features of Combined Central Retinal Artery and Vein Occlusion
Table 2
BCVA at presentation, 2 to 3 weeks after presentation, and at last follow-up.
| BCVA | At presentation | Two to 3 weeks after presentation | Last follow-up |
| ≥20/60 | 4 (12.1%) | 7 (21.9%) | 6 (23.1%) | 20/200–20/60 | 3 (9.1%) | 6 (18.8%) | 1 (3.8%) | 20/400–20/200 | 0 | 4 (12.5%) | 4 (15.4%) | 20/2000–20/400 | 11 (33.3%) | 11 (33.3%) | 9 (34.6%) | FC, LP, or NLP | 15 (45.5%) | 4 (12.5%) | 6 (23.1%) | Total (eyes) | 33 | 32 | 26 |
|
|